Please find enclosed scrutinizers report
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivo Bio Tech Limited conducted a postal ballot via remote e-voting from June 14 to July 13, 2025, seeking shareholder approval for two director appointments. Both resolutions passed with overwhelming majority — 100% of valid votes cast in favour of each. Resolution 1 approved the appointment of Ms. Priya Rajender Goda (DIN: 07402785) as Independent Director, with 80 members voting in favour (63,11,118 shares) and only 5 against (92 shares). Resolution 2 approved the appointment of Mr. Satyanarayana Vedula (DIN: 09070986) as Non-Executive Non-Independent Director, with 77 members voting in favour (63,17,756 shares) and 8 against (114 shares). No invalid votes were recorded in either case. Scrutinizer CS Vinay Babu Gade confirmed both resolutions were passed with the requisite majority.
Both director appointments are now formally approved by shareholders, completing the board reconstitution. The near-unanimous shareholder backing signals strong confidence in the nominees and is unlikely to have any negative impact on the stock.